期刊文献+

miR-20b直接靶向3′-UTR负性调节VEGF的表达 被引量:4

miR-20b Directly Targets 3′-untranslated Region of VEGF and Negatively Regulates Its Expression
下载PDF
导出
摘要 目的探讨miR-20b是否直接靶向VEGF 3′-非编码区(3′-UTR)而调控其表达。方法采用miRanda软件预测VEGF 3′-UTR是否存在miR-20b的结合位点;使用PCR方法扩增RAW264.7细胞VEGF基因3′-UTR序列,经双酶切后克隆到pmiR-RB-Report^(TM)质粒海肾荧光素酶的下游,得到pmiR-RB-Report TM-VEGF 3′-UTR双荧光素酶重组质粒,使用电泳法和测序法进行验证;将重组质粒或空质粒与miR-20b模拟物或其对照共转染HeLa细胞,24h后检测相应荧光素酶活性。结果 VEGF 3′-UTR存在miR-20b的结合位点;获得了含VEGF 3′-UTR的双荧光素酶报告载体;重组质粒与miR-20b模拟物共转染组HeLa细胞的荧光素酶活性明显低于空质粒转染组(P<0.05)。结论成功构建小鼠VEGF基因3′-UTR双荧光素酶报告载体,miR-20b可以直接靶向VEGF 3′-UTR而负性调控其表达。 Objective To investigate whether miR-20 bdirectly targets VEGF 3′-untranslated region(3′-UTR)and regulates its expression.Methods MiRanda software was used to predict the binding sites of miR-20 bto VEGF 3′-UTR.3′-UTR sequence of VEGF gene was amplified using polymerase chain reaction(PCR)in RAW264.7cells.PCR products were cloned into the downstream of Renilla luciferase in pmiR-RB-Report TMplasmid to obtain pmiR-RB-Report TM-VEGF 3′-UTR recombinant vector.Electrophoresis and DNA sequencing methods were used to verify the recombinant plasmid.The recombinant plasmid or empty plasmid and miR-20 bmimic or its control were co-transfected into HeLa cells and 24 hlater,the corresponding luciferase activity was detected by Dual-LuciferaseReporter Assay System.Results The recombinant dual luciferase reporter vectors with VEGF 3′-UTR were acquired.There was a binding site of miR-20 bto 3′-UTR of VEGF gene.The luciferase activity in HeLa cells transfected with recombinant plasmid and miR-20 bmimics was significantly lower than in the empty plasmid group(P〈0.05).Conclusion Mouse VEGF gene 3′-UTR dual luciferase reporter vector was successfully constructed.miR-20 bcould directly target VEGF gene 3′-UTR and negatively regulate its expression.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2016年第1期22-26,共5页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 国家自然科学基金资助项目(No.81273273) 安徽省自然科学基金资助项目(No.1308085MH114)
关键词 血管内皮生长因子 3′-非编码区 miR-20b 双荧光素酶报告载体 vascular endothelial growth factor 3′-untranslated region miR-20b dual luciferase reporter vector
  • 相关文献

参考文献15

  • 1Shibuya M. Vascular endothelial growth factor and its recep- tor system: physiological functions in angiogenesis and patho- logical roles in various diseases[J]. J Biochem, 2013,153 (1) : 13-19. 被引量:1
  • 2Ferrara N. Vascular endothelial growth factor[J]. Arterio- scler Thromb Vasc Biol, 2009,29 (6) : 789-791. 被引量:1
  • 3Amini A,Masoumi M S,Morris D L,et al. The critical role of vascular endothelial growth factor in tumor angiogenesis[J].Curr Cancer Drug Targets, 2012,12 (1) .. 23-43. 被引量:1
  • 4Lee C G,Ma B,Takyar S,et al. Studies of vascular endothelial growth factor in asthma and chronic obstructive pulmonary disease[J]. Proc Am Thorac Soc,2011,8(6) :512- 515. 被引量:1
  • 5Lonreiro R M, D' Amore P A. Transcriptional regulation of vascular endothelial growth factor in cancer[J]. Cytokine Growth Factor Rev, 2005,16 (1) : 77-89. 被引量:1
  • 6Song C, Ma H, Yao C, et al. Alveolar macrophage-derived vas- cular endothelial growth factor contributes to allergic airway inflammation in a mouse asthma model[J]. Scand J Immunol, 2012,75(6) :599-605. 被引量:1
  • 7Lee Y C,Kwak Y G,Song C H. Contribution of vascular en- dothelial growth factor to airway hyperresponsiveness and in- flammation in a murine model of toluene diisocyanate-induced asthma[J]. J Immunol, 2002,168(7) : 3595-3600. 被引量:1
  • 8Lee K Y,Lee K S,Park S J,et al. Clinical significance of plas- ma and serum vascular endothelial growth factor in asthma [J]. J Asthma,2008,45(9) : 735-739. 被引量:1
  • 9Abdel-Rahman A M,el-Sahrigy S A,Bakr S I. A comparative study of two angiogenic factors: vascular endothelial growth factor and angiogenin in induced sputum from asthmatic chil dren in acute attack[J]. Chest,2006,129(2) = 266-271. 被引量:1
  • 10Filipowicz W, Bhattacharyya S N, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the an- swers in sight? [J]. Nat Rev Genet,2008,9(2) = 102-114. 被引量:1

二级参考文献6

共引文献5

同被引文献45

  • 1ZHOU X Y, YUAN P, HE Y Z. Role of microRNAs in peripher-al artery disease (review)[J], Molecular Medicine Reports, 2012,6(4): 695-700. 被引量:1
  • 2CAPORALI A, EMANUEIJ C. MicroRNA-503 and the ex-tended microRNA-16 family in angiogenesis[J]. Trends in Car-diovascular Medicine, 2011,21(6): 162-166. 被引量:1
  • 3PAULMURUGAN R. Mici'oRNAs-a new generation moleculartargets for treating cellular diseases[J]. Theranostics, 2013,3(12):927-929. 被引量:1
  • 4VICKERS K C, RYE K A, TABET F. microRNAs in the onsetand development of cardiovascular disease[J]. Clinical Science,2014,126(3): 183-194. 被引量:1
  • 5KARNATI H K, PANIGRAHI M K, GUTTI R K, et al. miR-NAs: key players in neurodegenerative disorders and epilepsy[J].Journal of Alzheimer,s Disease, 2015, 48(3): 563-580. 被引量:1
  • 6MCCLELLAND A D, KANTHAKIDIS P. microRNA in the de-velopment of diabetic complications[J]. Clinical Science, 2014,126(2): 95-110. 被引量:1
  • 7WU W L, WANG W Y, YAO W Q, et al. Suppressive effects ofmicroRNA-16 on the proliferation, invasion and metastasis ofhepatocellular carcinoma cells[J]. International Journal of Molec-ular Medicine, 2015’ 36(6): 1713-1719. 被引量:1
  • 8DAI L X’ WANG W, ZHANG S, et al. Vector-based miR-15a/16-1 plasmid inhibits colon cancer growth in vivo\]\ Cell Bi-ology International, 2012, 36(8): 765-770. 被引量:1
  • 9ZHANG B, CHEN C F, WANG A H, et al. MiR-16 regulatescell death in Alzheimer's disease by targeting amyloid precur-sor protein [J]. European Review for Medical PharmacologicalSciences, 2015,19(21): 4020-4027. 被引量:1
  • 10BURAEI Z, YANG J. Structure and function of the /3 subunitof voltage-gated Ca2+ channels[J]. Biochimica et Biophysica Ac-ta, 2013,1828(7): 1530-1540. 被引量:1

引证文献4

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部